Paclitaxel: application in modern oncology and nanomedicine‐based cancer therapy

J Sharifi-Rad, C Quispe, JK Patra… - Oxidative medicine …, 2021 - Wiley Online Library
Paclitaxel is a broad‐spectrum anticancer compound, which was derived mainly from a
medicinal plant, in particular, from the bark of the yew tree Taxus brevifolia Nutt. It is a …

Progress in research on paclitaxel and tumor immunotherapy

L Zhu, L Chen - Cellular & molecular biology letters, 2019 - Springer
Paclitaxel is a well-known anticancer agent with a unique mechanism of action. It is
considered to be one of the most successful natural anticancer drugs available. This study …

Nanoscale drug delivery systems for cancer therapy using paclitaxel—A review of challenges and latest progressions

G Mustafa, D Hassan, G Ruiz-Pulido… - Journal of Drug Delivery …, 2023 - Elsevier
Paclitaxel (PTX) is an effective anticancer chemical with a broad spectrum that was primarily
obtained from a curative shrub, specifically the bark of Taxus brevifolia tree. It belongs to a …

Recent advances in boosting EGFR tyrosine kinase inhibitors-based cancer therapy

Q Pan, Y Lu, L Xie, D Wu, R Liu, W Gao… - Molecular …, 2023 - ACS Publications
Epidermal growth factor receptor (EGFR) plays a key role in signal transduction pathways
associated with cell proliferation, growth, and survival. Its overexpression and aberrant …

Chitooligosaccharides-modified PLGA nanoparticles enhance the antitumor efficacy of AZD9291 (Osimertinib) by promoting apoptosis

X Hu, S Chen, H Yin, Q Wang, Y Duan, L Jiang… - International Journal of …, 2020 - Elsevier
The nano drug delivery system (NDDS) has been extensively investigated for cancer
treatment because of its ability to enhance drug efficacy. However, there are only a few …

Pharmacoepigenetic processors: epigenetic drugs, drug resistance, toxicoepigenetics, and nutriepigenetics

R Cacabelos, JC Carril, A Sanmartín, P Cacabelos - Pharmacoepigenetics, 2019 - Elsevier
The pharmacoepigenetic apparatus is integrated by gene clusters of different categories,
including (i) pathogenic genes involved in disease pathogenesis,(ii) mechanistic genes …

Recent progress of paclitaxel delivery systems: covalent and noncovalent approaches

J Wang, X Li, W Wu, XM Xu, H Xu… - Advanced …, 2023 - Wiley Online Library
Paclitaxel (PTX) is a broad‐spectrum alkaloid anticancer drug with high therapeutic efficacy.
However, PTX has a very low water solubility and its metabolism demonstrates nonlinear …

Nanocarrier-mediated co-delivery systems for lung cancer therapy: recent developments and prospects

MA Farooq, M Aquib, DH Khan, S Ghayas… - Environmental …, 2019 - Springer
Research has recently focused on combinational therapy using nanocarriers to overcome
the obstacles associated with conventional therapy of lung cancer. The classical therapeutic …

Unveiling microtubule dynamics in lung cancer: Recent findings and prospects for drug delivery and treatment

MN Yukuyama, A de Souza, MAB Henostroza… - Journal of Drug Delivery …, 2023 - Elsevier
Microtubules are dynamic proteins that play crucial roles in the normal functions of cells.
Chromosome missegregation driven by microtubules during cell division can lead to several …

Low dose Taxol ameliorated renal fibrosis in mice with diabetic kidney disease by downregulation of HIPK2

Y Xia, H Jiang, J Chen, F Xu, G Zhang, D Zhang - Life Sciences, 2023 - Elsevier
Our previous studies reported that low-dose paclitaxel (Taxol) ameliorated renal fibrosis in
the unilateral ureteral obstruction and remnant kidney models. However, the regulatory role …